Publication | Closed Access

The anti-hepatitis drug DDB chemosensitizes multidrug resistant cancer cells in vitro and in vivo by inhibiting P-gp and enhancing apoptosis

OncologyAnti-hepatitis Drug DdbMedicineImmune Checkpoint InhibitorPharmacotherapyAnti-cancer AgentCancer TreatmentPharmacologyRadiation OncologyCancer ResearchDrug Discovery